CAROLINA Published: Reaffirms Sulfonylurea Cardiovascular Safety CAROLINA Published: Reaffirms Sulfonylurea Cardiovascular Safety
The study, presented to a European audience of diabetologists at EASD and simultaneously published in JAMA, reaffirms the CV safety of glimepiride, with calls for FDA warning to be removed.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Glimepiride | Heart | Study | Warnings